On 4 July 2018 the CMU adopted Resolutions No. 530 and No. 534 "On amending the List of Pharmaceuticals and Medical Devices that are procured based on procurement agreements with specialized procurement agencies with budget funds allocations in 2018 under Budget Program 2301400 "Ensuring Medical Activities of Certain State Programs and Complex Program Measures," approved by CMU Regulation No. 278 dated 28 March 2018. These resolutions became effective on 10 July 2018.

This resolution was supplemented with a number of pharmaceuticals for treating oncohaematological, cardiovascular and cerebrovascular diseases, chronic viral hepatitis and hypertension, etc.

Extension of this list is expected to enhance patient access to pharmaceuticals used for treatment of serious diseases.